药食同源代代花药理作用及应用研究进展

Research Progress on the Pharmacological Action and Application of Medicine-food Homologous Citrus aurantium L. var. amara Engl.

摘要:

代代花是药食同源目录公布的第一批中药材，含有挥发油类、黄酮类、多糖类、生物碱类、香豆素类等化学成分，具有抗氧化、抗炎、抗菌、抗病毒、抗肿瘤、降血脂等药理作用，在食品、医药、日化等行业有一定应用。作为保健产品组分或中药配方组分，其可起调节机体功能或治疗病症的作用，在大健康领域彰显独特的价值。近年来，代代花的关注度进一步提升，针对其药理作用及应用方面的研究逐渐增加。该研究系统梳理国内外相关研究，从代代花的药理作用以及应用现状等方面进行分析和总结，期望推进深入研究和开发代代花的发展进程，为未来研究和综合开发利用代代花提供理论依据。

Abstract:

Citrus aurantium L. var. amara Engl. (CAVA), which was the first batch of traditional Chinese medicines published in the catalogue of medicine and food homology, contains chemical components such as volatile oils, flavonoids, polysaccharides, alkaloids, and coumarins. It has pharmacological effects such as antioxidant, anti-inflammatory, antibacterial, antiviral, antitumor and hypolipidemic functions, and has been used in certain industrial applications including food, medicine and daily chemical products. As a component of a healthcare product or an ingredient of a traditional Chinese medicine formula, CAVA can play a role in regulating body functions or treating diseases, and demonstrates unique value in the big health field. In recent years, CAVA has drawn increasing interest, and research on its pharmacological effects and applications have grown over time. This article systematically reviewed the research related to CAVA from China and overseas, summarizes aspects such as the pharmacological functions and application status of CAVA, to promote the development process for in-depth research and development of CAVA, and provide a theoretical basis for future research and comprehensive development and utilization of CAVA.